Dividend Stock Analysis: Does Eli Lilly Have Enough Promise in Its Pipeline?

By Dividends Paid:Eli Lilly & Co. (LLY) discovers, develops, manufactures, and sells pharmaceutical products worldwide. LLY is the 10th largest pharmaceutical company in the world and operates in the healthcare sector. Dividend Reliability

By Ry Frank:Eli Lilly (LLY) is a major manufacturer of prescription drugs that treat a wide range of conditions. The company also has a division that produces animal health products. Sales to foreign countries comprise about 43% of total revenue.

The Dividend Pig submits:Leggett & Platt, Incorporated (LEG) is an international diversified manufacturer that conceives, designs, and produces a range of engineered components and products found in many homes, offices, retail stores and automobiles.

By ValueMax:Eli Lilly (LLY) discovers, develops, manufactures, and sells pharmaceutical products worldwide. Eli Lilly's headquarters are in Indianapolis, Ind. The company has a market cap of $56.8 billion, and its stock price is around $51.

By Alexander J. Poulos:Conservative income investors have seen their interest payments decline as the world continues to be ravaged by the global financial crisis. Interest earned on money markets and CDs, once a favored vehicle for retirees, now pay in many instances less than 1%. The U.S. government-issued 10-year bond is below 2%, which is hardly an appealing proposition. I am going to focus now on Eli Lilly (LLY), a U.S.

Steve Alexander submits:Eli Lilly (LLY) is one of the largest of the "big pharmaceutical" companies, focusing especially on the clinical areas of the nervous system, endocrine system (hormones), cancer, and the cardiovascular system (heart and lungs).

eChristian Investing submits:The first decade of the 21st century turned out to be less than stellar for many investors. The S&P 500 index, which had quadrupled during the 1990s, finished the decade down 24%. However, dividend investors managed to turn in a respectable performance despite the market’s turbulence. The current list of Dividend Aristocrats stocks delivered an average 104% total return for the decade.

Andrew Wilkinson submits: Eli Lilly & Co. (LLY) – Options investors are celebrating the pharmaceutical maker’s better-than-expected second-quarter earnings report, released ahead of today’s opening bell, by initiating bullish transactions on the stock.